Selected research
Industry Research
Recombinant Antibody Service Industry Research Report 2026
Market perspective
The global Recombinant Antibody Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Recombinant Antibody Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Recombinant Antibody Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Recombinant Antibody Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Recombinant Antibody Service include GenScript Biotech Corporation, Abcam plc, Creative Biolabs, Absolute Antibody Ltd., Thermo Fisher Scientific, ProteoGenix, Bio-Rad Laboratories, Rockland Immunochemicals Inc. and RayBiotech, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Recombinant Antibody Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Recombinant Antibody Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Antibody Service Market by Company
GenScript Biotech Corporation
Abcam plc
Creative Biolabs
Absolute Antibody Ltd.
Thermo Fisher Scientific
ProteoGenix
Bio-Rad Laboratories
Rockland Immunochemicals Inc.
RayBiotech, Inc.
Novoprotein Scientific Inc.
Sino Biological
Abnova
ACROBiosystems
Fitzgerald Industries International
Boster Biological Technology Co., Ltd.
Azenta Life Sciences
R&D Systems
Abcam
WuXi Biologics
Cell Signaling Technology, Inc.
Meridian Life Science Inc.
MabPlex Inc.
ProMab Biotechnologies
LakePharma(Curia)
Profacgen
Atlas Antibodies
Proteintech
BioLegend
OriGene Technologies
Biointron Biological
Detai Bio-Tech
FITGENE
Cusabio
GentleGen
TekBiotech
Recombinant Antibody Service Segment by Type
Antibody Discovery & Design Service
Recombinant Expression Service
Antibody Purification & Characterization Service
Recombinant Antibody Service Segment by Application
Biopharmaceuticals
Diagnostics
Research
Therapeutics
Recombinant Antibody Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Antibody Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Antibody Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Antibody Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Recombinant Antibody Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Recombinant Antibody Service Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Recombinant Antibody Service Revenue Market Share by Type (2021-2026)
Table 7. Global Recombinant Antibody Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Recombinant Antibody Service Revenue Market Share by Type (2027-2032)
Table 9. Global Recombinant Antibody Service Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Recombinant Antibody Service Revenue Market Share by Application (2021-2026)
Table 11. Global Recombinant Antibody Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Recombinant Antibody Service Revenue Market Share by Application (2027-2032)
Table 13. Global Recombinant Antibody Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Recombinant Antibody Service Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Recombinant Antibody Service Market Share by Region (2021-2026)
Table 16. Global Recombinant Antibody Service Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Recombinant Antibody Service Market Share by Region (2027-2032)
Table 18. Recombinant Antibody Service Industry Trends
Table 19. Recombinant Antibody Service Industry Drivers
Table 20. Recombinant Antibody Service Industry Opportunities and Challenges
Table 21. Recombinant Antibody Service Market Restraints
Table 22. Global Top Recombinant Antibody Service Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Recombinant Antibody Service Revenue Market Share by Players (2021-2026)
Table 24. Global Recombinant Antibody Service Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Recombinant Antibody Service, Headquarters and Area Served
Table 26. Global Recombinant Antibody Service Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Recombinant Antibody Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Recombinant Antibody Service Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Recombinant Antibody Service Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Recombinant Antibody Service Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Recombinant Antibody Service Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Recombinant Antibody Service Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Recombinant Antibody Service Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Recombinant Antibody Service Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Recombinant Antibody Service Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Recombinant Antibody Service Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Recombinant Antibody Service Market Size by Country (2027-2032) & (US$ Million)
Table 45. GenScript Biotech Corporation Company Information
Table 46. GenScript Biotech Corporation Business Overview
Table 47. GenScript Biotech Corporation Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 48. GenScript Biotech Corporation Recombinant Antibody Service Product Portfolio
Table 49. GenScript Biotech Corporation Recent Developments
Table 50. Abcam plc Company Information
Table 51. Abcam plc Business Overview
Table 52. Abcam plc Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 53. Abcam plc Recombinant Antibody Service Product Portfolio
Table 54. Abcam plc Recent Developments
Table 55. Creative Biolabs Company Information
Table 56. Creative Biolabs Business Overview
Table 57. Creative Biolabs Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 58. Creative Biolabs Recombinant Antibody Service Product Portfolio
Table 59. Creative Biolabs Recent Developments
Table 60. Absolute Antibody Ltd. Company Information
Table 61. Absolute Antibody Ltd. Business Overview
Table 62. Absolute Antibody Ltd. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 63. Absolute Antibody Ltd. Recombinant Antibody Service Product Portfolio
Table 64. Absolute Antibody Ltd. Recent Developments
Table 65. Thermo Fisher Scientific Company Information
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 68. Thermo Fisher Scientific Recombinant Antibody Service Product Portfolio
Table 69. Thermo Fisher Scientific Recent Developments
Table 70. ProteoGenix Company Information
Table 71. ProteoGenix Business Overview
Table 72. ProteoGenix Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 73. ProteoGenix Recombinant Antibody Service Product Portfolio
Table 74. ProteoGenix Recent Developments
Table 75. Bio-Rad Laboratories Company Information
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 78. Bio-Rad Laboratories Recombinant Antibody Service Product Portfolio
Table 79. Bio-Rad Laboratories Recent Developments
Table 80. Rockland Immunochemicals Inc. Company Information
Table 81. Rockland Immunochemicals Inc. Business Overview
Table 82. Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 83. Rockland Immunochemicals Inc. Recombinant Antibody Service Product Portfolio
Table 84. Rockland Immunochemicals Inc. Recent Developments
Table 85. RayBiotech, Inc. Company Information
Table 86. RayBiotech, Inc. Business Overview
Table 87. RayBiotech, Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 88. RayBiotech, Inc. Recombinant Antibody Service Product Portfolio
Table 89. RayBiotech, Inc. Recent Developments
Table 90. Novoprotein Scientific Inc. Company Information
Table 91. Novoprotein Scientific Inc. Business Overview
Table 92. Novoprotein Scientific Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 93. Novoprotein Scientific Inc. Recombinant Antibody Service Product Portfolio
Table 94. Novoprotein Scientific Inc. Recent Developments
Table 95. Sino Biological Company Information
Table 96. Sino Biological Business Overview
Table 97. Sino Biological Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 98. Sino Biological Recombinant Antibody Service Product Portfolio
Table 99. Sino Biological Recent Developments
Table 100. Abnova Company Information
Table 101. Abnova Business Overview
Table 102. Abnova Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 103. Abnova Recombinant Antibody Service Product Portfolio
Table 104. Abnova Recent Developments
Table 105. ACROBiosystems Company Information
Table 106. ACROBiosystems Business Overview
Table 107. ACROBiosystems Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 108. ACROBiosystems Recombinant Antibody Service Product Portfolio
Table 109. ACROBiosystems Recent Developments
Table 110. Fitzgerald Industries International Company Information
Table 111. Fitzgerald Industries International Business Overview
Table 112. Fitzgerald Industries International Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 113. Fitzgerald Industries International Recombinant Antibody Service Product Portfolio
Table 114. Fitzgerald Industries International Recent Developments
Table 115. Boster Biological Technology Co., Ltd. Company Information
Table 116. Boster Biological Technology Co., Ltd. Business Overview
Table 117. Boster Biological Technology Co., Ltd. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 118. Boster Biological Technology Co., Ltd. Recombinant Antibody Service Product Portfolio
Table 119. Boster Biological Technology Co., Ltd. Recent Developments
Table 120. Azenta Life Sciences Company Information
Table 121. Azenta Life Sciences Business Overview
Table 122. Azenta Life Sciences Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 123. Azenta Life Sciences Recombinant Antibody Service Product Portfolio
Table 124. Azenta Life Sciences Recent Developments
Table 125. R&D Systems Company Information
Table 126. R&D Systems Business Overview
Table 127. R&D Systems Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 128. R&D Systems Recombinant Antibody Service Product Portfolio
Table 129. R&D Systems Recent Developments
Table 130. Abcam Company Information
Table 131. Abcam Business Overview
Table 132. Abcam Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 133. Abcam Recombinant Antibody Service Product Portfolio
Table 134. Abcam Recent Developments
Table 135. WuXi Biologics Company Information
Table 136. WuXi Biologics Business Overview
Table 137. WuXi Biologics Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 138. WuXi Biologics Recombinant Antibody Service Product Portfolio
Table 139. WuXi Biologics Recent Developments
Table 140. Cell Signaling Technology, Inc. Company Information
Table 141. Cell Signaling Technology, Inc. Business Overview
Table 142. Cell Signaling Technology, Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 143. Cell Signaling Technology, Inc. Recombinant Antibody Service Product Portfolio
Table 144. Cell Signaling Technology, Inc. Recent Developments
Table 145. Meridian Life Science Inc. Company Information
Table 146. Meridian Life Science Inc. Business Overview
Table 147. Meridian Life Science Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 148. Meridian Life Science Inc. Recombinant Antibody Service Product Portfolio
Table 149. Meridian Life Science Inc. Recent Developments
Table 150. MabPlex Inc. Company Information
Table 151. MabPlex Inc. Business Overview
Table 152. MabPlex Inc. Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 153. MabPlex Inc. Recombinant Antibody Service Product Portfolio
Table 154. MabPlex Inc. Recent Developments
Table 155. ProMab Biotechnologies Company Information
Table 156. ProMab Biotechnologies Business Overview
Table 157. ProMab Biotechnologies Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 158. ProMab Biotechnologies Recombinant Antibody Service Product Portfolio
Table 159. ProMab Biotechnologies Recent Developments
Table 160. LakePharma(Curia) Company Information
Table 161. LakePharma(Curia) Business Overview
Table 162. LakePharma(Curia) Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 163. LakePharma(Curia) Recombinant Antibody Service Product Portfolio
Table 164. LakePharma(Curia) Recent Developments
Table 165. Profacgen Company Information
Table 166. Profacgen Business Overview
Table 167. Profacgen Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 168. Profacgen Recombinant Antibody Service Product Portfolio
Table 169. Profacgen Recent Developments
Table 170. Atlas Antibodies Company Information
Table 171. Atlas Antibodies Business Overview
Table 172. Atlas Antibodies Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 173. Atlas Antibodies Recombinant Antibody Service Product Portfolio
Table 174. Atlas Antibodies Recent Developments
Table 175. Proteintech Company Information
Table 176. Proteintech Business Overview
Table 177. Proteintech Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 178. Proteintech Recombinant Antibody Service Product Portfolio
Table 179. Proteintech Recent Developments
Table 180. BioLegend Company Information
Table 181. BioLegend Business Overview
Table 182. BioLegend Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 183. BioLegend Recombinant Antibody Service Product Portfolio
Table 184. BioLegend Recent Developments
Table 185. OriGene Technologies Company Information
Table 186. OriGene Technologies Business Overview
Table 187. OriGene Technologies Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 188. OriGene Technologies Recombinant Antibody Service Product Portfolio
Table 189. OriGene Technologies Recent Developments
Table 190. Biointron Biological Company Information
Table 191. Biointron Biological Business Overview
Table 192. Biointron Biological Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 193. Biointron Biological Recombinant Antibody Service Product Portfolio
Table 194. Biointron Biological Recent Developments
Table 195. Detai Bio-Tech Company Information
Table 196. Detai Bio-Tech Business Overview
Table 197. Detai Bio-Tech Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 198. Detai Bio-Tech Recombinant Antibody Service Product Portfolio
Table 199. Detai Bio-Tech Recent Developments
Table 200. FITGENE Company Information
Table 201. FITGENE Business Overview
Table 202. FITGENE Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 203. FITGENE Recombinant Antibody Service Product Portfolio
Table 204. FITGENE Recent Developments
Table 205. Cusabio Company Information
Table 206. Cusabio Business Overview
Table 207. Cusabio Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 208. Cusabio Recombinant Antibody Service Product Portfolio
Table 209. Cusabio Recent Developments
Table 210. GentleGen Company Information
Table 211. GentleGen Business Overview
Table 212. GentleGen Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 213. GentleGen Recombinant Antibody Service Product Portfolio
Table 214. GentleGen Recent Developments
Table 215. TekBiotech Company Information
Table 216. TekBiotech Business Overview
Table 217. TekBiotech Revenue in Recombinant Antibody Service Business (2021-2026) & (US$ Million)
Table 218. TekBiotech Recombinant Antibody Service Product Portfolio
Table 219. TekBiotech Recent Developments
Table 220. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Recombinant Antibody Service Product Image
Figure 5. Global Recombinant Antibody Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Recombinant Antibody Service Market Share by Type: 2025 VS 2032
Figure 7. Antibody Discovery & Design Service Product
Figure 8. Recombinant Expression Service Product
Figure 9. Antibody Purification & Characterization Service Product
Figure 10. Global Recombinant Antibody Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Recombinant Antibody Service Market Share by Application: 2025 VS 2032
Figure 12. Biopharmaceuticals Product
Figure 13. Diagnostics Product
Figure 14. Research Product
Figure 15. Therapeutics Product
Figure 16. Global Recombinant Antibody Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Recombinant Antibody Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Recombinant Antibody Service Market Share by Region: 2025 VS 2032
Figure 19. Global Recombinant Antibody Service Market Share by Players in 2025
Figure 20. Global Recombinant Antibody Service Manufacturers Established Date
Figure 21. Global Top 5 and 10 Recombinant Antibody Service Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 25. United States Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 28. Europe Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 30. Germany Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 40. China Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 45. Australia Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Recombinant Antibody Service Market Share by Country (2021-2032)
Figure 50. Brazil Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Recombinant Antibody Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 56. Abcam plc Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 57. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 58. Absolute Antibody Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 60. ProteoGenix Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 62. Rockland Immunochemicals Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 63. RayBiotech, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 64. Novoprotein Scientific Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 65. Sino Biological Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 66. Abnova Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 67. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 68. Fitzgerald Industries International Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 69. Boster Biological Technology Co., Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 70. Azenta Life Sciences Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 71. R&D Systems Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 72. Abcam Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 73. WuXi Biologics Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 74. Cell Signaling Technology, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 75. Meridian Life Science Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 76. MabPlex Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 77. ProMab Biotechnologies Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 78. LakePharma(Curia) Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 79. Profacgen Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 80. Atlas Antibodies Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 81. Proteintech Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 82. BioLegend Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 83. OriGene Technologies Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 84. Biointron Biological Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 85. Detai Bio-Tech Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 86. FITGENE Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 87. Cusabio Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 88. GentleGen Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Figure 89. TekBiotech Revenue Growth Rate in Recombinant Antibody Service Business (2021-2026)
Scope & coverage.
Types
- Antibody Discovery & Design Service
- Recombinant Expression Service
- Antibody Purification & Characterization Service
Applications
- Biopharmaceuticals
- Diagnostics
- Research
- Therapeutics
Companies covered
- GenScript Biotech Corporation
- Abcam plc
- Creative Biolabs
- Absolute Antibody Ltd.
- Thermo Fisher Scientific
- ProteoGenix
- Bio-Rad Laboratories
- Rockland Immunochemicals Inc.
- RayBiotech, Inc.
- Novoprotein Scientific Inc.
- Sino Biological
- Abnova
- ACROBiosystems
- Fitzgerald Industries International
- Boster Biological Technology Co., Ltd.
- Azenta Life Sciences
- R&D Systems
- Abcam
- WuXi Biologics
- Cell Signaling Technology, Inc.
- Meridian Life Science Inc.
- MabPlex Inc.
- ProMab Biotechnologies
- LakePharma(Curia)
- Profacgen
- Atlas Antibodies
- Proteintech
- BioLegend
- OriGene Technologies
- Biointron Biological
- Detai Bio-Tech
- FITGENE
- Cusabio
- GentleGen
- TekBiotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Recombinant Antibody Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Antibody Discovery & Design Service
- 2.2.3 Recombinant Expression Service
- 2.2.4 Antibody Purification & Characterization Service
- 2.3 Recombinant Antibody Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceuticals
- 2.3.3 Diagnostics
- 2.3.4 Research
- 2.3.5 Therapeutics
- 2.4 Assumptions and Limitations
3 Recombinant Antibody Service Breakdown Data by Type
- 3.1 Global Recombinant Antibody Service Historic Market Size by Type (2021-2026)
- 3.2 Global Recombinant Antibody Service Forecasted Market Size by Type (2027-2032)
4 Recombinant Antibody Service Breakdown Data by Application
- 4.1 Global Recombinant Antibody Service Historic Market Size by Application (2021-2026)
- 4.2 Global Recombinant Antibody Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Recombinant Antibody Service Market Perspective (2021-2032)
- 5.2 Global Recombinant Antibody Service Growth Trends by Region
- 5.2.1 Global Recombinant Antibody Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Recombinant Antibody Service Historic Market Size by Region (2021-2026)
- 5.2.3 Recombinant Antibody Service Forecasted Market Size by Region (2027-2032)
- 5.3 Recombinant Antibody Service Market Dynamics
- 5.3.1 Recombinant Antibody Service Industry Trends
- 5.3.2 Recombinant Antibody Service Market Drivers
- 5.3.3 Recombinant Antibody Service Market Challenges
- 5.3.4 Recombinant Antibody Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Recombinant Antibody Service Players by Revenue
- 6.1.1 Global Top Recombinant Antibody Service Players by Revenue (2021-2026)
- 6.1.2 Global Recombinant Antibody Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Recombinant Antibody Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Recombinant Antibody Service Head Office and Area Served
- 6.4 Global Recombinant Antibody Service Players, Product Type & Application
- 6.5 Global Recombinant Antibody Service Manufacturers Established Date
- 6.6 Global Recombinant Antibody Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Recombinant Antibody Service Market Size (2021-2032)
- 7.2 North America Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Recombinant Antibody Service Market Size by Country (2021-2026)
- 7.4 North America Recombinant Antibody Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Recombinant Antibody Service Market Size (2021-2032)
- 8.2 Europe Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Recombinant Antibody Service Market Size by Country (2021-2026)
- 8.4 Europe Recombinant Antibody Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Antibody Service Market Size (2021-2032)
- 9.2 Asia-Pacific Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Recombinant Antibody Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Recombinant Antibody Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Recombinant Antibody Service Market Size (2021-2032)
- 10.2 South America Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Recombinant Antibody Service Market Size by Country (2021-2026)
- 10.4 South America Recombinant Antibody Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Antibody Service Market Size (2021-2032)
- 11.2 Middle East & Africa Recombinant Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Recombinant Antibody Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Recombinant Antibody Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GenScript Biotech Corporation
- 12.1.1 GenScript Biotech Corporation Company Information
- 12.1.2 GenScript Biotech Corporation Business Overview
- 12.1.3 GenScript Biotech Corporation Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.1.4 GenScript Biotech Corporation Recombinant Antibody Service Product Portfolio
- 12.1.5 GenScript Biotech Corporation Recent Developments
- 12.2 Abcam plc
- 12.2.1 Abcam plc Company Information
- 12.2.2 Abcam plc Business Overview
- 12.2.3 Abcam plc Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.2.4 Abcam plc Recombinant Antibody Service Product Portfolio
- 12.2.5 Abcam plc Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.3.4 Creative Biolabs Recombinant Antibody Service Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 Absolute Antibody Ltd.
- 12.4.1 Absolute Antibody Ltd. Company Information
- 12.4.2 Absolute Antibody Ltd. Business Overview
- 12.4.3 Absolute Antibody Ltd. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.4.4 Absolute Antibody Ltd. Recombinant Antibody Service Product Portfolio
- 12.4.5 Absolute Antibody Ltd. Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Recombinant Antibody Service Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 ProteoGenix
- 12.6.1 ProteoGenix Company Information
- 12.6.2 ProteoGenix Business Overview
- 12.6.3 ProteoGenix Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.6.4 ProteoGenix Recombinant Antibody Service Product Portfolio
- 12.6.5 ProteoGenix Recent Developments
- 12.7 Bio-Rad Laboratories
- 12.7.1 Bio-Rad Laboratories Company Information
- 12.7.2 Bio-Rad Laboratories Business Overview
- 12.7.3 Bio-Rad Laboratories Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.7.4 Bio-Rad Laboratories Recombinant Antibody Service Product Portfolio
- 12.7.5 Bio-Rad Laboratories Recent Developments
- 12.8 Rockland Immunochemicals Inc.
- 12.8.1 Rockland Immunochemicals Inc. Company Information
- 12.8.2 Rockland Immunochemicals Inc. Business Overview
- 12.8.3 Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.8.4 Rockland Immunochemicals Inc. Recombinant Antibody Service Product Portfolio
- 12.8.5 Rockland Immunochemicals Inc. Recent Developments
- 12.9 RayBiotech, Inc.
- 12.9.1 RayBiotech, Inc. Company Information
- 12.9.2 RayBiotech, Inc. Business Overview
- 12.9.3 RayBiotech, Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.9.4 RayBiotech, Inc. Recombinant Antibody Service Product Portfolio
- 12.9.5 RayBiotech, Inc. Recent Developments
- 12.10 Novoprotein Scientific Inc.
- 12.10.1 Novoprotein Scientific Inc. Company Information
- 12.10.2 Novoprotein Scientific Inc. Business Overview
- 12.10.3 Novoprotein Scientific Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.10.4 Novoprotein Scientific Inc. Recombinant Antibody Service Product Portfolio
- 12.10.5 Novoprotein Scientific Inc. Recent Developments
- 12.11 Sino Biological
- 12.11.1 Sino Biological Company Information
- 12.11.2 Sino Biological Business Overview
- 12.11.3 Sino Biological Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.11.4 Sino Biological Recombinant Antibody Service Product Portfolio
- 12.11.5 Sino Biological Recent Developments
- 12.12 Abnova
- 12.12.1 Abnova Company Information
- 12.12.2 Abnova Business Overview
- 12.12.3 Abnova Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.12.4 Abnova Recombinant Antibody Service Product Portfolio
- 12.12.5 Abnova Recent Developments
- 12.13 ACROBiosystems
- 12.13.1 ACROBiosystems Company Information
- 12.13.2 ACROBiosystems Business Overview
- 12.13.3 ACROBiosystems Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.13.4 ACROBiosystems Recombinant Antibody Service Product Portfolio
- 12.13.5 ACROBiosystems Recent Developments
- 12.14 Fitzgerald Industries International
- 12.14.1 Fitzgerald Industries International Company Information
- 12.14.2 Fitzgerald Industries International Business Overview
- 12.14.3 Fitzgerald Industries International Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.14.4 Fitzgerald Industries International Recombinant Antibody Service Product Portfolio
- 12.14.5 Fitzgerald Industries International Recent Developments
- 12.15 Boster Biological Technology Co., Ltd.
- 12.15.1 Boster Biological Technology Co., Ltd. Company Information
- 12.15.2 Boster Biological Technology Co., Ltd. Business Overview
- 12.15.3 Boster Biological Technology Co., Ltd. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.15.4 Boster Biological Technology Co., Ltd. Recombinant Antibody Service Product Portfolio
- 12.15.5 Boster Biological Technology Co., Ltd. Recent Developments
- 12.16 Azenta Life Sciences
- 12.16.1 Azenta Life Sciences Company Information
- 12.16.2 Azenta Life Sciences Business Overview
- 12.16.3 Azenta Life Sciences Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.16.4 Azenta Life Sciences Recombinant Antibody Service Product Portfolio
- 12.16.5 Azenta Life Sciences Recent Developments
- 12.17 R&D Systems
- 12.17.1 R&D Systems Company Information
- 12.17.2 R&D Systems Business Overview
- 12.17.3 R&D Systems Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.17.4 R&D Systems Recombinant Antibody Service Product Portfolio
- 12.17.5 R&D Systems Recent Developments
- 12.18 Abcam
- 12.18.1 Abcam Company Information
- 12.18.2 Abcam Business Overview
- 12.18.3 Abcam Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.18.4 Abcam Recombinant Antibody Service Product Portfolio
- 12.18.5 Abcam Recent Developments
- 12.19 WuXi Biologics
- 12.19.1 WuXi Biologics Company Information
- 12.19.2 WuXi Biologics Business Overview
- 12.19.3 WuXi Biologics Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.19.4 WuXi Biologics Recombinant Antibody Service Product Portfolio
- 12.19.5 WuXi Biologics Recent Developments
- 12.20 Cell Signaling Technology, Inc.
- 12.20.1 Cell Signaling Technology, Inc. Company Information
- 12.20.2 Cell Signaling Technology, Inc. Business Overview
- 12.20.3 Cell Signaling Technology, Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.20.4 Cell Signaling Technology, Inc. Recombinant Antibody Service Product Portfolio
- 12.20.5 Cell Signaling Technology, Inc. Recent Developments
- 12.21 Meridian Life Science Inc.
- 12.21.1 Meridian Life Science Inc. Company Information
- 12.21.2 Meridian Life Science Inc. Business Overview
- 12.21.3 Meridian Life Science Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.21.4 Meridian Life Science Inc. Recombinant Antibody Service Product Portfolio
- 12.21.5 Meridian Life Science Inc. Recent Developments
- 12.22 MabPlex Inc.
- 12.22.1 MabPlex Inc. Company Information
- 12.22.2 MabPlex Inc. Business Overview
- 12.22.3 MabPlex Inc. Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.22.4 MabPlex Inc. Recombinant Antibody Service Product Portfolio
- 12.22.5 MabPlex Inc. Recent Developments
- 12.23 ProMab Biotechnologies
- 12.23.1 ProMab Biotechnologies Company Information
- 12.23.2 ProMab Biotechnologies Business Overview
- 12.23.3 ProMab Biotechnologies Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.23.4 ProMab Biotechnologies Recombinant Antibody Service Product Portfolio
- 12.23.5 ProMab Biotechnologies Recent Developments
- 12.24 LakePharma(Curia)
- 12.24.1 LakePharma(Curia) Company Information
- 12.24.2 LakePharma(Curia) Business Overview
- 12.24.3 LakePharma(Curia) Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.24.4 LakePharma(Curia) Recombinant Antibody Service Product Portfolio
- 12.24.5 LakePharma(Curia) Recent Developments
- 12.25 Profacgen
- 12.25.1 Profacgen Company Information
- 12.25.2 Profacgen Business Overview
- 12.25.3 Profacgen Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.25.4 Profacgen Recombinant Antibody Service Product Portfolio
- 12.25.5 Profacgen Recent Developments
- 12.26 Atlas Antibodies
- 12.26.1 Atlas Antibodies Company Information
- 12.26.2 Atlas Antibodies Business Overview
- 12.26.3 Atlas Antibodies Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.26.4 Atlas Antibodies Recombinant Antibody Service Product Portfolio
- 12.26.5 Atlas Antibodies Recent Developments
- 12.27 Proteintech
- 12.27.1 Proteintech Company Information
- 12.27.2 Proteintech Business Overview
- 12.27.3 Proteintech Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.27.4 Proteintech Recombinant Antibody Service Product Portfolio
- 12.27.5 Proteintech Recent Developments
- 12.28 BioLegend
- 12.28.1 BioLegend Company Information
- 12.28.2 BioLegend Business Overview
- 12.28.3 BioLegend Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.28.4 BioLegend Recombinant Antibody Service Product Portfolio
- 12.28.5 BioLegend Recent Developments
- 12.29 OriGene Technologies
- 12.29.1 OriGene Technologies Company Information
- 12.29.2 OriGene Technologies Business Overview
- 12.29.3 OriGene Technologies Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.29.4 OriGene Technologies Recombinant Antibody Service Product Portfolio
- 12.29.5 OriGene Technologies Recent Developments
- 12.30 Biointron Biological
- 12.30.1 Biointron Biological Company Information
- 12.30.2 Biointron Biological Business Overview
- 12.30.3 Biointron Biological Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.30.4 Biointron Biological Recombinant Antibody Service Product Portfolio
- 12.30.5 Biointron Biological Recent Developments
- 12.31 Detai Bio-Tech
- 12.31.1 Detai Bio-Tech Company Information
- 12.31.2 Detai Bio-Tech Business Overview
- 12.31.3 Detai Bio-Tech Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.31.4 Detai Bio-Tech Recombinant Antibody Service Product Portfolio
- 12.31.5 Detai Bio-Tech Recent Developments
- 12.32 FITGENE
- 12.32.1 FITGENE Company Information
- 12.32.2 FITGENE Business Overview
- 12.32.3 FITGENE Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.32.4 FITGENE Recombinant Antibody Service Product Portfolio
- 12.32.5 FITGENE Recent Developments
- 12.33 Cusabio
- 12.33.1 Cusabio Company Information
- 12.33.2 Cusabio Business Overview
- 12.33.3 Cusabio Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.33.4 Cusabio Recombinant Antibody Service Product Portfolio
- 12.33.5 Cusabio Recent Developments
- 12.34 GentleGen
- 12.34.1 GentleGen Company Information
- 12.34.2 GentleGen Business Overview
- 12.34.3 GentleGen Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.34.4 GentleGen Recombinant Antibody Service Product Portfolio
- 12.34.5 GentleGen Recent Developments
- 12.35 TekBiotech
- 12.35.1 TekBiotech Company Information
- 12.35.2 TekBiotech Business Overview
- 12.35.3 TekBiotech Revenue in Recombinant Antibody Service Business (2021-2026)
- 12.35.4 TekBiotech Recombinant Antibody Service Product Portfolio
- 12.35.5 TekBiotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst